Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Stem cells in prostate cancer initiation and progression
Devon A. Lawson, Owen N. Witte
Devon A. Lawson, Owen N. Witte
Published August 1, 2007
Citation Information: J Clin Invest. 2007;117(8):2044-2050. https://doi.org/10.1172/JCI32810.
View: Text | PDF
Review Series

Stem cells in prostate cancer initiation and progression

  • Text
  • PDF
Abstract

Peter Nowell and David Hungerford’s discovery of the Philadelphia chromosome facilitated many critical studies that have led to a paradigm shift in our understanding of cancer as a disease of stem cells. This Review focuses on the application of these concepts to investigation of the role of stem cells in prostate cancer initiation and progression. Major strides in the development of in vitro and in vivo assays have enabled identification and characterization of prostate stem cells as well as functional evaluation of the tumorigenic effects of prostate cancer–related genetic alterations.

Authors

Devon A. Lawson, Owen N. Witte

×

Figure 1

Models of prostate epithelial cell differentiation.

Options: View larger image (or click on image) Download as PowerPoint
Models of prostate epithelial cell differentiation.
In traditional linea...
In traditional linear hierarchy models, self-renewing PSCs residing in the basal cell (BC) layer give rise to transit-amplifying cells (TACs) of intermediate phenotypes that may express both basal and luminal cell markers during their maturation. These cells theoretically possess transient self-renewal activity and produce large numbers of terminally differentiated secretory luminal cells (LCs). In bifurcated models, basal cells and luminal cells represent separate epithelial cell lineages. These lineages may be sustained by intermediate transit-amplifying cells and/or lineage-restricted basal and luminal cell progenitors (BP and LP, respectively).

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts